A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response

A 3-Year Observational Study of Patients with Progressive Systemic Sclerosis Treated with an Intensified B Lymphocyte Depletion Protocol: Clinical and Immunological Response

Background: B-cells have been suggested to play a role in the pathogenesis of systemic sclerosis (SSc), representing, therefore, a potential therapeutic target. Objectives: We aimed at investigating the 36-month outcomes of 20 SSc patients who underwent an intensified B-depletion therapy (IBCDT) sch...

Full description

Bibliographic Details
Main Authors: Daniela Rossi, Savino Sciascia, Irene Cecchi, Marta Saracco, Erika Montabone, Vittorio Modena, Raffaele Pellerito, Renato Carignola, Dario Roccatello
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
rituximab
systemic sclerosis
scleroderma
intensified B-depletion therapy
Online Access:https://www.mdpi.com/2077-0383/10/2/292

Internet

https://www.mdpi.com/2077-0383/10/2/292

Similar Items